Pilot Study of Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation: Double-blind, Randomized, Sham-controlled, Investigator-initiated Trial
This study is a Double-blind, Randomized, Sham-controlled, Investigator-initiated trial. To explore the effectiveness of non-invasive inner ear electrical stimulation of the mastoid behind the ear in controlling auditory symptoms and dizziness in patients with Meniere's disease.
• Patients with dizziness (Meniere's) only, who understand the nature of the study and are willing to participate voluntarily.
• The frequency of the hearing loss is between 250 kHz and 1 kHz.
• Patients with bilateral 500, 1000, and 2000 Hz hearing threshold averages within 65 dB HL
• Patients who have received conventional pharmacotherapy for other dizziness conditions with a washout period of 2 months.
• To be eligible for subjects in the active phase of the disease, there must be at least 1 vertigo attack in the 6 months before study entry.
• If tests for renal function, electrolytes, etc. are performed and no problems are found